CBE ID
2474
Endorsed
New or Maintenance
Is Under Review
No
Measure Description
Rate of cardiac tamponade and/or pericardiocentesis following atrial fibrillation (AF) ablation.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisMAT output not attachedAttachedNumerator
The number of patients from the denominator with cardiac tamponade and/or pericardiocentesis occurring within 30 days following atrial fibrillation ablation.
DenominatorAll patients aged 18 years and older with atrial fibrillation ablation performed during the reporting period.
ExclusionsNo exclusions.
All information required to stratify the measure resultsOffAll information required to stratify the measure resultsOffTesting Data Sources
- Measure StructureClinical Condition Topic AreaNon Condition SpecificTarget PopulationMeasure Selection AttributesNational Quality Strategy PrioritiesClinical Preventive ServicesHealth and Well-Being
- Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
- Current or planned use(s)Planned Use
- Most Recent Endorsement ActivityEndorsed Cardiovascular Project 2014-2015Initial EndorsementNext Planned Maintenance ReviewFall 2025Endorsement StatusLast Updated
- Do you have a secondary measure developer point of contact?OffThe measure developer is NOT the same as measure stewardOffStewardSteward Organization EmailSteward Organization Copyright
© 2014 Heart Rhythm Society. All Rights Reserved.
- Detailed Measure SpecificationsNoLogic ModelOffImpact and GapNoFeasibility assessment methodology and resultsNoAddress health equityNoMeasure’s use or intended useNo508 ComplianceOffIf no, attest that all information will be provided in other fields in the submission.Off